Compare Amphastar Pharmaceuticals Inc (AMPH) vs J B Hunt Transport Services Inc (JBHT) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

JBHT trades at $279.96, down 0.94% today, with a bullish technical outlook supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected soon. Revenue has stabilized around $12B annually, while profitability metrics show a net margin of 5.13% and ROE of 16.68%. Analyst sentiment remains positive with 57.78% buy ratings.

The stock presents a mixed valuation with elevated P/E of 43.47 but reasonable EV/EBITDA of 17.18. Near-term catalysts include Q2 earnings release on July 15, 2026. Key risks include freight market volatility and competitive pressures. The consensus price target of $273.93 suggests limited upside from current levels despite strong institutional support.